a cell produced by the fusion of an antibody-producing cell and a lymphoma (cancer) cell for production of monoclonal antibodies
A permanent cell line generated by cell fusion that secretes a specific monoclonal antibody.
Cell line used in the production of monoclonal antibodies; obtained by fusing antibody-secreting B lymphocytes with cells of a lymphocyte tumor.
a cell arising from chemical fusion of two parental cell lines
a cell which is obtained by cell fusion between a B cell obtained by immunizing a mammal other than human with an antigen and a myeloma cell derived from mouse or the like and can produce a monoclonal antibody having the desired antigen specificity
a new cell resulting from the fusion of a particular type of immortal tumour cell line (one that divides continuously) , such as a myeloma, with an antibody-producing B lymphocyte
an immortalized cell line which is capable of secreting a specific monoclonal antibody
The cell produced by fusing two cells of different origin. In monoclonal antibody technology, hybridomas are formed by fusing an immortal cell (one that divides continuously) and an antibody-producing cell. See also Monoclonal antibody; Myeloma.
the cell produced by the fusion of an antibody-producing cell and a multiple myeloma cell; this cell can produce a continuous supply of antibody.
A cell produced by the fusion of an antibody-producing cell with a myeloma cell; it produces monoclonal antibodies.
The cell which results from the fusion of an antibody producing tumor cell (myeloma) and an antigenically-stimulated normal plasma cell. Such cells are constructed because they produce a single antibody directed against the antigen epitope which stimulated the plasma cell. This antibody is referred to as a monoclonal antibody.
Cell line created in vitro by fusing two different cell types, usually lymphocytes, one of which is a tumour cell.
A cell formed by the fusion of an antibody-producing cell with a tumour cell. A hybridoma inherits the specificity of the antibody-producing cell and the immortality of the tumor cell.
Hybridoma cells are cells that have been engineered to produce a desired antibody in large amounts. To produce monoclonal antibodies, B-cells are removed from the spleen of an animal that has been challenged with the relevant antigen. These B-cells are then fused with myeloma tumor cells that can grow indefinitely in culture (myeloma is a B-cell cancer).